AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ADRO Quote Aduro Biote

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 75 158 126
ShortTermInvest 272 168 140
Cash 347 326 266
AccountReceivab 1 1 12
Inventories 0 0 0
DeferredIncomeT 6 0 0
OtherCurrentAss 0 17 0
TotalCurrentAss 355 350 283
PPE 30 38 41
AccumulatedDepr -4 -7 -11
NetPPE 26 31 29
EquityAndOtherI 14 24 11
Goodwill 8 9 8
IntangibleAsset 28 31 25
OtherLTAssets 1 0 0
TotalNonCurrent 84 95 75
TotalAssets 439 445 358
ShortTermDebt 0 0 0
AccountsPayable 2 1 1
TaxesPayable 1 0 0
AccruedLiabilit 8 13 8
DeferredRevenue 15 15 16
OtherCurrentLia 4 12 5
TotalCurrentLia 31 41 31
Debt 0 0 0
DeferredTaxesLi 6 7 6
DeferredRevenue 163 148 173
OtherLTLiabilit 12 12 13
TotalNonCurrent 181 166 192
TotalLiabilitie 211 208 222
CommonStock 0 0 0
AdditionalPaidI 421 519 539
RetainedEarning -192 -284 -405
AccumulatedOthe -2 2 1
TotalStockholde 227 237 135
TotalLiabilitie 439 445 358
Aduro Biotech Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Aduro Biotech Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.